CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 44 enrolled
Drug / intervention
Olympus +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02182804
NCT02182804N/ACompleted
CompareCT.gov

Diagnostic Values of Probe-based Confocal Laser Endomicroscopy (pCLE) and Magnifying Narrow Band Imaging (M-NBI) for Early Neoplasms Detection in Esophageal Lugol'S-voiding Lesions.

King Chulalongkorn Memorial Hospital·interventional·Posted Jul 8, 2014·Updated Aug 28, 2020

In Brief

A clinical study evaluating Olympus and Cellvizio for Esophageal Neoplasms. Completed, enrolled 44 participants.

Detailed Summary

This descriptive cross sectional study aims to directly compare the diagnostic capability of the probed-based confocal laser endomicroscopy (pCLE) and the magnifying narrow band imaging (M-NBI) in the Lugol's voiding lesions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEsophageal Neoplasms
Countries--
CollaboratorsChulalongkorn University

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 8, 2014
Enrollment StartFeb 1, 2013
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.0 years ago

Interventions

Olympusdevice

narrow band imaging with magnification

Cellviziodevice

probe-based confocal laser endomicroscopy